Sella Provan

45PUBLICATIONS
119CO-AUTHORS
Respiratory diseasesNephrology and urologyReinforcement learningApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|May 07, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

|Apr 23, 2026
Duration and dose of allopurinol needed to attain the serum urate target in gout.

|Apr 06, 2026
Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration.

Zubeyir Salis, Denis Mongin, Denis Choquette

|Mar 19, 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Teresa Holly, Marthe Kirkesaether Brun, Kristin Kaasen Jørgensen

|Nov 10, 2025
Psychometric evaluation of the Norwegian version of the Revised Fibromyalgia Impact Questionnaire.

S A Provan, H Berner-Hammer, A L Kleppang

|Sep 03, 2025
Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study.

Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg

Pageof 8

Frequent Collaborators

12 joint publications

Bente Glintborg

11 joint publications

Merete Lund Hetland

10 joint publications

Tore Kristian Kvien

9 joint publications

Daniela Di Giuseppe